Rhythm Pharmaceuticals buy Wells Fargo & Company
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€48.34
Performance (%)
-3.30%
Price
18:23
€41.00
Summary
This prediction is currently active. With a performance of -3.30%, the BUY prediction for Rhythm Pharmaceuticals by Wells_Fargo___Compan is down slightly. This prediction currently runs until 19.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Rhythm Pharmaceuticals | 10.929% | 10.929% |
iShares Core DAX® | -0.922% | -1.078% |
iShares Nasdaq 100 | 0.371% | -0.556% |
iShares Nikkei 225® | 2.224% | -2.825% |
iShares S&P 500 | -0.026% | -0.788% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Wells Fargo & Company from $48.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€26.00
08.11.23
08.11.23
€37.40
08.11.24
08.11.24
57.69%
18:23
18:23